Maltodapoh
Latest Information Update: 06 Sep 2002
At a glance
- Originator Reliable Biopharmaceutical Corporation
- Class Anticoagulants; Antithrombotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 29 Nov 1999 New profile
- 29 Nov 1999 Preclinical development for Thrombosis in USA (PO)